Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (45)

2023

  1. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder

    Drug and Alcohol Dependence, Vol. 245

  2. Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort

    Clinical Microbiology and Infection, Vol. 29, Núm. 4, pp. 498-505

  3. Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival

    Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1695-1703

  4. Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients With Coronavirus Disease 2019: Impact on the Length of Hospital Stay and Mortality

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 1, pp. 32-38

  5. Treatment variability and its relationships to outcomes among patients with Wernicke's encephalopathy: A multicenter retrospective study

    Drug and Alcohol Dependence, Vol. 252

2022

  1. Alcoholic Liver Disease Among Patients with Wernicke Encephalopathy: A Multicenter Observational Study

    Drug and Alcohol Dependence, Vol. 230

  2. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

  3. Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)

    Autoimmunity Reviews, Vol. 21, Núm. 10

2021

  1. Clinical characterization and outcomes of 85 patients with neurosarcoidosis

    Scientific Reports, Vol. 11, Núm. 1

  2. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    Joint Bone Spine, Vol. 88, Núm. 6

  3. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

  4. The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)

    Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880

2020

  1. Candida bloodstream infection in patients with systemic autoimmune diseases

    Medecine et Maladies Infectieuses, Vol. 50, Núm. 4, pp. 372-376

  2. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study

    The Lancet Infectious Diseases, Vol. 20, Núm. 12, pp. 1409-1417

  3. Serodiscordant patients with systemic sclerosis: When antibody does not correspond to skin involvement

    Clinical and Experimental Rheumatology, Vol. 38, pp. S106-S114

2019

  1. Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients

    European Journal of Internal Medicine, Vol. 69, pp. 77-85

  2. The Big Data Sjögren consortium: A project for a new data science era

    Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23

2018

  1. Association between allelic variants of the human glucocorticoid receptor gene and autoimmune diseases: A systematic review and meta-analysis

    Autoimmunity Reviews, Vol. 17, Núm. 5, pp. 449-456

  2. Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis

    Journal of Infection, Vol. 76, Núm. 4, pp. 342-347

  3. The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs

    Expert Review of Clinical Pharmacology, Vol. 11, Núm. 10, pp. 999-1030